Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

Lilly wins FDA nod for Humalog pre-filled Junior KwikPen device
Drug Delivery Business News
Wed, 06/14/17 - 09:05 pm
Tags:
Eli Lilly, FDA, Humalog, devices, diabetes, Junior KwikPen
J&J's Invokana lowers CV risk, but by enough to compete?
BioPharma Dive
Wed, 06/14/17 - 11:37 am
Tags:
JNJ, Invokana, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim
ADA: Merck, Pfizer notch success, but late with SGLT-2 data
BioPharma Dive
Tue, 06/13/17 - 12:15 pm
Tags:
diabetes, Merck, Pfizer, SGLT2 inhibitor, Januvia, Invokana, Farxiga, Jardiance, Eli Lilly, Boehringer Ingelheim, AstraZeneca, JNJ
Eli Lilly posts promising PhIII migraine results, but settles into the pack in the last leg of the race to the FDA
Endpoints
Sun, 06/11/17 - 04:58 pm
Tags:
Eli Lilly, migraines, galcanezumab
ADA preview: 5 things to watch in diabetes
BioPharma Dive
Sun, 06/11/17 - 09:30 am
Tags:
ADA, diabetes, Jardiance, Eli Lilly, Boehringer Ingelheim, Lantus, Tresiba, JNJ, Novo Nordisk, PCSK9 inhibitors, Amgen Regeneron, Sanofi, Apple, Google, insulin
Lilly preps galcanezumab for 2017 filing
BioPharma Dive
Sun, 06/11/17 - 09:15 am
Tags:
Eli Lilly, galcanezumab, migraines, FDA
Lilly drops $55M for access to new class of diabetes drugs
BioPharma Dive
Thu, 06/8/17 - 09:58 pm
Tags:
Eli Lilly, diabetes, dual amylin calcitonin receptor agonists, DACRAs, Key Bioscience, KBP-042
Top 10 diabetes drugs by 2016 sales
Fierce Pharma
Thu, 06/8/17 - 10:04 am
Tags:
diabetes, Sanofi, Novo Nordisk, Eli Lilly, Merck, Lantus, Januvia, Victoza, Levemir, Humalog, Novolog, Invokana
Lilly's Strattera faces first wave of generic competition
BioPharma Dive
Fri, 06/2/17 - 11:31 am
Tags:
Eli Lilly, Strattera, generics, ADHD, Apotex, Aurobindo, Glenmark, Teva Pharmaceutical
Top Presentations to Look for at ASCO
Yahoo/24-7 Wall St
Tue, 05/30/17 - 11:35 am
Tags:
ASCO 2017, Merck, AbbVie, Eli Lilly, Bluebird Bio, Epizyme, Juno Therapeutics, Kite, Merus
Eli Lilly-backed Symic raises $30M round as it preps for a pivotal trial
Endpoints
Tue, 05/23/17 - 08:23 am
Tags:
Eli Lilly, Symic, clinical trials, osteoarthritis, matrix biology
Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets
Fierce Pharma
Mon, 05/22/17 - 07:48 pm
Tags:
Nevada, drug pricing, Sanofi, Novo Nordisk, insulin, Eli Lilly, diabetes
Former Lilly employee wins an ironic lawsuit over disability benefits
Stat
Mon, 05/22/17 - 12:20 pm
Tags:
Eli Lilly, disabilities, fibromyalgia, Cymbalta
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
Tags:
ASCO 2017, oncology, Incyte, Merck, Eli Lilly, CAR-T, NewLink Genetics, Amgen, Roche, Kite Pharma, Juno Therapeutics
ASCO: Lilly's abemaciclib vs. Pfizer's Ibrance? Too early to make a call, analysts say
Fierce Pharma
Thu, 05/18/17 - 08:00 pm
Tags:
ASCO 2017, Eli Lilly, Pfizer, abemaciclib, Ibrance, breast cancer
Playing catch-up, Eli Lilly is hustling positive PhIII CGRP migraine data to the FDA as late-stage rivalry heats up
Endpoints
Fri, 05/12/17 - 11:39 am
Tags:
Eli Lilly, migraines, galcanezumab
Novo’s diabetes medication Victoza keeps growing, despite Lilly’s market-share creep
Fierce Pharma
Thu, 05/4/17 - 10:08 am
Tags:
Novo Nordisk, Victoza, diabetes, Eli Lilly, Trulicity
These 7 Drugmakers Relied on Price Hikes for 100% of Their Earnings Growth in 2016
Motley Fool
Sat, 04/29/17 - 10:12 am
Tags:
earnings, drug pricing, Biogen, Eli Lilly, AbbVie, Allergan, Merck, Pfizer, Amgen
2 Reasons Eli Lilly is Getting Crushed
Barron's
Wed, 04/26/17 - 12:00 am
Tags:
Eli Lilly, earnings, Jardiance, diabetes, baricitinib
Deal charge pushes drugmaker Eli Lilly to 1Q loss
Yahoo/AP
Tue, 04/25/17 - 11:30 am
Tags:
earnings, Eli Lilly, CoLucid Pharmaceuticals, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.